KXT-12282-66481
1 vaccination
1 coded response
9 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 191 / PA
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-17
Dose 1 — Pfizer-BioNTech
-
2020-12-18
Registered in v-safe
-
2020-12-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-24
- 2020-12-31
- 2021-06-19
-
2021-12-19
Survey response — 12 months, dose 1MedDRA: Carditis, Office visit — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professionalFree text: Symptoms: heart inflammation · Healthcare visit (other): Visit with cardiologistMedDRA releases: 2024-11 · check-in free text available
-
2021-12-19
Report sent to call center — 12 months, dose 1Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-12-22
-
2021-12-22
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
Free text
Release 10 — 12 months, dose 1
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Carditis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release